Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia

Endocrine Journal

Volumn 43, Issue 1, 1996, Pages 119-123

  Yanase, Toshihiko ^a   Fukahori, Motofumi ^b   Taniguchi, Susumu ^a   Nishi, Yoshihiro ^a   Sakai, Yoshiyuki ^a   Takayanagi, Ryoichi ^a   Haji, Masafumi ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Mitate Hospital   (Japan)

Author keywords

Alzheimer's disease; Cerebrovascular dementia; Dehydroepiandrosterone (DHEA); DHEA sulfate

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

ADRENARCHE; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MALE;

EID: 0029871868     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.119     Document Type: Article

References (18)

1. Parker LN, Odell WD (1980) Control of adrenal androgen secretion. Endocr Rev 1: 392-410.
2. Schartz AG, Whitcomb JM, Nyce JW, Lewbart ML, Pashko LL (1988) Dehydroepiandrosterone and structural anlogues: A new class of cancer chemporeventive agent. Adv Cancer Res 51:391-424.
3. Flood JF, Roberts E (1988) Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 448: 178-181.
4. Flood JF, Smith GE, Roberts E (1988) Dehydroepiandrosterone and its sulfate enhance memory retension in mice. Brain Res 447: 267-278.
5. Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molchan SE, Martinez R, Murphy DL (1989) Reduced plasma dehydroepiandrosterone concentration in Alzheimer's disease. Lancet ii: 570.
6. Nasman B, Olsson T, Backstom T, Erikson S, Grankvist K, Viltanen M, Bucht G (1991) Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 30: 684-690.
7. Svec F, Lopez-SA (1989) Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease. Lancet i: 1335.
8. Spath-Schwalbe E, Dodt, C, Dittmann J, Schuttler R, Fehn HL (1990) Dehydroepiandrosterone sulfate in Alzheimer disease. Lancet i:1412.
9. Leblhuber F, Windhager E, Reisecker F, Steinparz FX, Dienstl E (1990) Dehydroepiandrosterone sulfate in Alzheimer's disease. Lancet ii: 449.
10. Cuckle H, Stone R, Smith D, Wald N, Brammer M, Hajimohammedreza I, Levy R, Chard T, Perry L (1990) Dehydroepiandrosterone sulfate in Alzheimer's disease. Lancet ii: 449-450.
11. Leblhuber F, Windhager E, Steinparz FX, Dienstl E, Reisecker F, Rittmannsberger H (1991) Dehydroepiandrosterone-sulfate (DHEAS) serum levels in normal aging and Alzheimer's disease. Age 14: 116-118.
12. Schneider LS, Hinsey M, Lyness S (1992) Plasma dehydroepiandrosteone sulfate in Alzheimer's disease. Biol Scychiatry 31: 205-208.
13. Takahashi S, Oono H, Someya T (1995) Authorized translation of the original English language edition, "Quick Reference to the Diagnostic Criteria from DSM-IV" first published in the United States by American Psychiatric Association, Washington D.C., Igaku-shoin Ltd., Tokyo.
14. Ogo A, Haji M, Natori S, Yanase T, Nawata H, Kato K (1988) Fundamental and clinical studies on a solid-phase radioimmunoassay kit for the quantitative measurement of DHEA. Clin Endocrinol (Tokyo) 36: 95-100.
15. Ogo A, Haji M, Natori S, Yanase T, Nawata H, Kato K (1988) Fundamental and clinical studies on a solid-phase radioimmunoassay kit for the quantitative measurement of DHEA-S. Clin Endocrinol (Tokyo) 36: 179-184.
16. Atack JR, Beal MF, May C, Kaye JA, Mazurek MF, Kay AD, Rapoport SI (1988) Cerebrospinal fluid somatostatin and neuropeptide Y. concentrations in aging and in dementia of the Alzheimer tye with and without extrapyramidal signs. Arch Neurol 45: 269-274.
17. Alom J, Galard R, Catalan R, Castellanos JM, Schwastz S, Tolosa E (1990) Cerebrospinal fluid neuropeptide Y in Alzheimer's disease. Eur Neurol 30: 207-210.
18. Mellon SH (1994) Neurosteroids: Biochemistry, mode of action, and clinical relevance. J Clin Endocrinol Metab 78: 1003-1008.